These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 32775374)
21. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis. Ju Q; Li XM; Zhang H; Zhao YJ Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929 [TBL] [Abstract][Full Text] [Related]
22. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity. Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K Gene; 2019 Oct; 716():144025. PubMed ID: 31394177 [TBL] [Abstract][Full Text] [Related]
23. Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma. Han J; Wang Y; Zhou H; Ai S; Wan D Comput Math Methods Med; 2022; 2022():6267851. PubMed ID: 36238495 [TBL] [Abstract][Full Text] [Related]
24. Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining. Lin J; Chen L; Wu D; Lin J; Liu B; Guo C Comput Math Methods Med; 2022; 2022():1372879. PubMed ID: 35813444 [TBL] [Abstract][Full Text] [Related]
25. Protein Regulator of Cytokinesis 1 (PRC1) Upregulation Promotes Immune Suppression in Liver Hepatocellular Carcinoma. Zhang C; Xu H; Sui X; Wu T; Chen B; Wang S; Wang X J Immunol Res; 2022; 2022():7073472. PubMed ID: 35983074 [TBL] [Abstract][Full Text] [Related]
26. Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma. Pang Y; Tan G; Yang X; Lin Y; Chen Y; Zhang J; Xie T; Zhou H; Fang J; Zhao Q; Ren X; Li J; Lyu J; Wang Z Cancer Cell Int; 2021 Sep; 21(1):463. PubMed ID: 34488769 [TBL] [Abstract][Full Text] [Related]
27. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA. Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216 [TBL] [Abstract][Full Text] [Related]
28. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma. Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158 [No Abstract] [Full Text] [Related]
29. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis. Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468 [TBL] [Abstract][Full Text] [Related]
30. Expression and prognosis analysis of Li H; Li Q; Jing H; Zhao J; Zhang H; Ma X; Wei L; Dai R; Sun W; Suo Z Front Biosci (Landmark Ed); 2021 Oct; 26(10):707-716. PubMed ID: 34719199 [No Abstract] [Full Text] [Related]
31. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer. Li L; Feng Q; Wang X Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050 [TBL] [Abstract][Full Text] [Related]
32. Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma. Hu P; Cui H; Lei T; Li S; Mai E; Jia F Onco Targets Ther; 2019; 12():9367-9376. PubMed ID: 31807017 [TBL] [Abstract][Full Text] [Related]
33. NPM3 as an Unfavorable Prognostic Biomarker Involved in Oncogenic Pathways of Lung Adenocarcinoma Chen L; Yang D; Huang F; Xu W; Luo X; Mei L; He Y Comb Chem High Throughput Screen; 2024; 27(2):203-213. PubMed ID: 37114782 [TBL] [Abstract][Full Text] [Related]
34. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma. Chen G; Mo S; Yuan D Biomed Res Int; 2021; 2021():9911784. PubMed ID: 34195286 [TBL] [Abstract][Full Text] [Related]
35. Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer. Yang K; Li C; Liu Y; Gu X; Jiang L; Shi L Cells; 2022 Apr; 11(9):. PubMed ID: 35563733 [TBL] [Abstract][Full Text] [Related]
36. Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma. Wu SY; Liao P; Yan LY; Zhao QY; Xie ZY; Dong J; Sun HT BMC Gastroenterol; 2021 Nov; 21(1):416. PubMed ID: 34724892 [TBL] [Abstract][Full Text] [Related]
37. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts. Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171 [TBL] [Abstract][Full Text] [Related]
38. The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma. Li W; Liu J Front Immunol; 2022; 13():845585. PubMed ID: 35757728 [TBL] [Abstract][Full Text] [Related]
39. Role of CD5 molecular-like on hepatocellular carcinoma. Gao Z; Wu X; Yang L; Liu C; Wang X; Wang H; Dong K Chin Med J (Engl); 2023 Mar; 136(5):556-564. PubMed ID: 36939243 [TBL] [Abstract][Full Text] [Related]
40. Effect of let-7c on the PI3K/Akt/FoxO signaling pathway in hepatocellular carcinoma. Li Y; Li P; Wang N Oncol Lett; 2021 Feb; 21(2):96. PubMed ID: 33376529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]